ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Ovarian disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
2,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3,2,Headache,Headaches NEC,Headaches,Nerv,N
3,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
4,2,Metaplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
5,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
5,2,Metaplasia,Trophic disorders,Tissue disorders NEC,Genrl,Y
6,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
7,2,Blood corticotrophin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
7,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
9,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
11,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
12,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
13,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
14,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
14,2,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
14,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
16,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
17,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
17,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
17,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
18,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
18,2,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
18,3,Tracheomalacia,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
19,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
20,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
20,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
21,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
22,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
22,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
23,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
23,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,4,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
23,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
23,6,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
24,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
24,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
24,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
25,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
26,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
26,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
26,3,Pneumonia influenzal,Influenza viral infections,Viral infectious disorders,Infec,N
26,4,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
26,5,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
26,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
27,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
27,3,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
27,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
27,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
27,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
28,2,Headache,Headaches NEC,Headaches,Nerv,N
28,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
30,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
